• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Avalo Therapeutics, Inc. - Common Stock (NQ: AVTX )

    8.910 -0.170 (-1.87%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 949,861
    Open 9.100
    Bid (Size) 8.910 (2)
    Ask (Size) 12.00 (3)
    Prev. Close 9.080
    Today's Range 8.670 - 9.810
    52wk Range 3.950 - 34.46
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
    From Avalo Therapeutics
    Via GlobeNewswire
    Avalo Therapeutics to Present at Upcoming Investor Conferences
    From Avalo Therapeutics
    Via GlobeNewswire

    Performance

    YTD
    +2.30%
    +2.30%
    1 Month
    -12.04%
    -12.04%
    3 Month
    -7.86%
    -7.86%
    6 Month
    -33.66%
    -33.66%
    1 Year
    -28.61%
    -28.61%

    More News

    Read More
    Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates
    From Avalo Therapeutics
    Via GlobeNewswire
    Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
    From Avalo Therapeutics
    Via GlobeNewswire
    Avalo Announces Participation in September Investor Conferences
    From Avalo Therapeutics
    Via GlobeNewswire
    Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q2 2024
    Via InvestorPlace
    Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
    From Avalo Therapeutics
    Via GlobeNewswire
    The 3 Best Personalized Nutrition Stocks to Buy Now
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer
    From Avalo Therapeutics
    Via GlobeNewswire
    Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa
    From Avalo Therapeutics
    Via GlobeNewswire
    Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
    From Avalo Therapeutics
    Via GlobeNewswire
    Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
    From Avalo Therapeutics
    Via GlobeNewswire
    AVTX Stock Earnings: Avalo Therapeutics Misses EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
    From Avalo Therapeutics
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
    From Avalo Therapeutics
    Via GlobeNewswire
    Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.